找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Global Perspectives in Ocular Oncology; Bhavna V. Chawla,Mary E. Aronow Book 2022 The Editor(s) (if applicable) and The Author(s), under e

[復(fù)制鏈接]
樓主: 爆裂
41#
發(fā)表于 2025-3-28 16:26:02 | 只看該作者
42#
發(fā)表于 2025-3-28 18:44:18 | 只看該作者
https://doi.org/10.1007/978-3-319-27853-7ncome countries (LMICs). Early detection and urgent referral to a specialized retinoblastoma treatment center is of utmost importance in order to save life, salvage the eye, and, in selected cases, retain vision. Advances in retinoblastoma screening, detection, and management in high-income countrie
43#
發(fā)表于 2025-3-29 01:23:41 | 只看該作者
44#
發(fā)表于 2025-3-29 03:46:42 | 只看該作者
45#
發(fā)表于 2025-3-29 09:17:57 | 只看該作者
https://doi.org/10.1007/978-1-4842-9568-7boplatin, etoposide, and vincristine (CEV). This regimen is efficacious when used as chemoreduction (a neoadjuvant strategy to shrink intraocular tumors) as well as in the adjuvant setting post-enucleation and to treat orbital disease when combined with surgery and radiation therapy..Concerns raised
46#
發(fā)表于 2025-3-29 12:42:05 | 只看該作者
47#
發(fā)表于 2025-3-29 18:31:03 | 只看該作者
48#
發(fā)表于 2025-3-29 20:00:11 | 只看該作者
https://doi.org/10.1007/978-3-031-31816-0c accuracy. The risk for relapse is high and relapse into the CNS can be fatal. The optimal treatment for PVRL is yet to be established. Therapeutic options are limited by drug penetration through the blood–retinal and blood–brain barriers, but different routes of delivery attempt to circumvent thes
49#
發(fā)表于 2025-3-30 00:25:22 | 只看該作者
50#
發(fā)表于 2025-3-30 04:42:07 | 只看該作者
https://doi.org/10.1007/978-0-8176-4591-5ce. The general ophthalmologist is often faced with challenges of not only diagnosing them accurately and managing them optimally, but also with inadequate knowledge and approach to genetic/systemic evaluation and counseling patient and family. This chapter addresses some of the common and infrequen
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 18:28
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
湘西| 清水县| 中牟县| 昌黎县| 宁阳县| 江都市| 天水市| 浦北县| 郁南县| 普宁市| 乐业县| 突泉县| 平潭县| 织金县| 台安县| 马边| 泰和县| 广南县| 义马市| 都安| 静海县| 姜堰市| 新沂市| 新泰市| 沂源县| 开阳县| 宁武县| 舟山市| 清远市| 高州市| 横山县| 石景山区| 昌乐县| 泗阳县| 建阳市| 泌阳县| 淮滨县| 柘荣县| 都安| 郑州市| 肥东县|